Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

A woman was apparently hit by not one, but two cars within minutes! It happened in Sakarya, Turkey. Reports say the woman was ...

ANOTHER year, another promise that the NHS is being radically reformed to slash waiting lists. Given that they are 40 per ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

It looks like your typical marriage proposal. The guy gets down on one knee an pops the question while holding up a wedding ...

A headline saying that tech billionaire Elon Musk had just bought Boeing spread online in December along with other false ...

Elon Musk said on Monday he was ready to provide Italy with secure communication services after Prime Minister Giorgia Meloni ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...

Over the years, Elon Musk's dramatic transformation has led to online trolling over his restored hairline and slightly ...